Cloning, expression, post-translational modifications and inhibition studies on the latest mammalian carbonic anhydrase isoform, CA XV

Journal of Medicinal Chemistry

Volumn 52, Issue 3, 2009, Pages 646-654

  Hilvo, Mika ^a   Salzano, Anna Maria ^b   Innocenti, Alessio ^c   Kulomaa, Markku S ^a   Scozzafava, Andrea ^b   Scaloni, Andrea ^c   Parkkila, Seppo ^a,d   Supuran, Claudiu T ^c  

^a UNIVERSITY OF TAMPERE   (Finland)

^b CNR   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BRINZOLAMIDE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE 15; CARBONATE DEHYDRATASE 6; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE INHIBITOR; CARBONATE DEHYDRATASE IV; CARBONATE DEHYDRATASE XII; CELECOXIB; DORZOLAMIDE; ETHOXZOLAMIDE; ISOENZYME; METHAZOLAMIDE; SULFONAMIDE; SULTIAME; UNCLASSIFIED DRUG; CARBONIC ANHYDRASE XV, MOUSE;

ANIMAL CELL; ARTICLE; CATALYSIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG RESPONSE; ENZYME INHIBITION; ENZYME PURIFICATION; KIDNEY; MOLECULAR CLONING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROCESSING; ANIMAL; ENZYMOLOGY; GENETICS; METABOLISM; MOUSE;

ANIMALS; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; CLONING, MOLECULAR; ISOENZYMES; KIDNEY; MICE; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 61449129341     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm801267c     Document Type: Article

References (48)

1. (a) Supuran, C. T. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat. Rev. Drug Discovery 2008, 7, 168181.
2. (b) Supuran, C. T. Carbonic anhydrases: catalytic and inhibition mechanisms, distribution and physiological roles. In Carbonic Anhy- drase: Its Inhibitors and Activators; Supuran, C. T., Scozzafava, A., Conway, J., Eds.; CRC Press: Boca Raton, 2004; pp 1-23.
3. Zimmerman, S. A.; Ferry, J. G. The beta and gamma classes of carbonic anhydrase. Curr. Pharm. Des. 2008, 14, 716-721.
4. Sly, W. S.; Hu, P. Y. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu. Rev. Biochem. 1995, 64, 375-401.
5. Pastorekova, S.; Pastorek, J. Cancer-related carbonic anhydrase isozymes and their inhibition. In Carbonic Anhydrase: Its Inhibitors and Activators; Supuran, C. T., Scozzafava, A., Conway, J., Eds.; CRC Press: Boca Raton, 2004; pp 255-281.
6. Montgomery, J. C.; Venta, P. J.; Eddy, R. L.; Fukushima, Y. S.; Shows, T. B.; Tashian, R. E. Characterization of the human gene for a newly discovered carbonic anhydrase, CA VII, and its localization to chromosome 16. Genomics 1991, 11, 835-848.
7. Lehtonen, J.; Shen, B.; Vihinen, M.; Casini, A.; Scozzafava, A.; Supuran, C. T.; Parkkila, A. K.; Saarnio, J.; Kivela, A. J.; Waheed, A.; Sly, W. S.; Parkkila, S. Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family. J. Biol. Chem. 2004, 279, 2719-2727.
8. Fujikawa-Adachi, K.; Nishimori, I.; Taguchi, T.; Onishi, S. Human mitochondrial carbonic anhydrase VB. cDNA cloning, mRNA expression, subcellular localization, and mapping to chromosome x. J. Biol. Chem. 1999, 274, 21228-21233.
9. Murakami, H.; Sly, W. S. Purification and characterization of human salivary carbonic anhydrase. J. Biol. Chem. 1987, 262, 1382-1388.
10. Pastorek, J.; Pastorekova, S.; Callebaut, I.; Mornon, J. P.; Zelnik, V.; Opavsky, R.; Zat'ovicová, M.; Liao, S.; Portetelle, D.; Stanbridge, E. J.; Závada, J.; Burny, A.; Kettmann, R. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 1994, 9, 2877-2888.
11. Türeci, Ö.; Sahin, U.; Vollmar, E.; Siemer, S.; Gottert, E.; Seitz, G.; Parkkila, A. K.; Shah, G. N.; Grubb, J. H.; Pfreundschuh, M.; Sly, W. S. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 7608-7613.
12. Fujikawa-Adachi, K.; Nishimori, I.; Taguchi, T.; Onishi, S. Human carbonic anhydrase XIV (CA14): cDNA cloning, mRNA expression, and mapping to chromosome 1. Genomics 1991, 61, 74-81.
13. Zhu, X. L.; Sly, W. S. Carbonic anhydrase IV from human lung. Purification, characterization, and comparison with membrane carbonic anhydrase from human kidney. J. Biol. Chem. 1990, 265, 8795-8801.
14. Hilvo, M.; Tolvanen, M.; Clark, A.; Shen, B.; Shah, G. N.; Waheed, A.; Halmi, P.; Hanninen, M.; Hämäläinen, J. M.; Vihinen, M.; Sly, W. S.; Parkkila, S. Characterization of CA XV, a new GPI-anchored form of carbonic anhydrase. Biochem. J. 2005, 392, 83-92.
15. Hilvo, M.; Innocenti, A.; Monti, S. M.; De Simone, G.; Supuran, C. T.; Parkkila, S. Recent advances in research on the most novel carbonic anhydrases, CA XIII and XV. Curr. Pharm. Des. 2008, 14, 672-678.
16. Hilvo, M.; Baranauskiene, L.; Salzano, A. M.; Scaloni, A.; Matulis, D.; Innocenti, A.; Scozzafava, A.; Monti, S. M.; Di Fiore, A.; De Simone, G.; Lindfors, M.; Janis, J.; Valjakka, J.; Pastoreková, S.; Pastorek, J.; Kulomaa, M. S.; Nordlund, H. R.; Supuran, C. T.; Parkkila, S. Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes. J. Biol. Chem. 2008, 283, 27799-27809.
17. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
18. Khalifah, R. G. The carbon dioxide hydration activity of carbonic anhydrase I. Stop-flow kinetic studies on the native human isoenzymes B and C. J. Biol. Chem. 1971, 246, 2561-2573.
19. (a) Nishimori, I.; Vullo, D.; Innocenti, A.; Scozzafava, A.; Mas- trolorenzo, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XIV with sulfonamides. Bioorg. Med. Chem. Lett. 2005, 15, 3828-3833.
20. (b) Nishimori, I.; Vullo, D.; Innocenti, A.; Scozzafava, A.; Mastrolorenzo, A.; Supuran, C. T. Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors. J. Med. Chem. 2005, 48, 7860-7866.
21. (c) Nishimori, I.; Minakuchi, T.; Morimoto, K.; Sano, S.; Onishi, S.; Takeuchi, H.; Vullo, D.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors. DNA cloning and inhibition studies of the a-carbonic anhydrase from Helicobacter pylori: a new target for developing sulfonamide and sulfamate gastric drugs. J. Med. Chem. 2006, 49, 2117-2126.
22. (d) Nishimori, I.; Minakuchi, T.; Onishi, S.; Vullo, D.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors. DNA cloning, characterization and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors. J. Med. Chem. 2007, 50, 381-388.
23. (a) Nishimori, I.; Onishi, S.; Takeuchi, H.; Supuran, C. T. The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets. Curr. Pharm. Des. 2008, 14, 622-630.
24. 2 sensing with cAMP signalling and virulence. Curr. Biol. 2005, 15, 2021-2026.
25. Guazel, O.; Innocenti, A.; Scozzafava, A.; Salman, A.; Parkkila, S.; Hilvo, M.; Supuran, C. T. Carbonic anhydrase inhibitors: Synthesis and inhibition studies against mammalian isoforms I-XV with a series of -(hydrazinocarbonyl)-3-substituted-phenyl-1 H-indole-5-sulfona- mides. Bioorg. Med. Chem. 2008, 16, in press (PMID: 18819811).
26. (a) Scozzafava, A.; Briganti, F.; Ilies, M. A.; Supuran, C. T. Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes. J. Med. Chem. 2000, 43, 292-300.
27. (b) Scozzafava, A.; Menabuoni, L.; Mincione, F.; Supuran, C. T. Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino- polycarboxylate tails and of their metal complexes possessing long- lasting, topical intraocular pressure-lowering properties. J. Med. Chem. 2002, 45, 1466-1476.
28. (c) Scozzafava, A.; Menabuoni, L.; Mincione, F.; Mincione, G.; Supuran, C. T. Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating DTPA tails and of their zinc complexes with powerful topical antiglaucoma properties. Bioorg. Med. Chem. Lett. 2001, 11, 575-582.
29. De Simone, G.; Di Fiore, A.; Menchise, V.; Pedone, C.; Antel, J.; Casini, A.; Scozzafava, A.; Wurl, M.; Supuran, C. T. Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: Solution and X-ray crystallographic studies. Bioorg. Med. Chem. Lett. 2005, 15, 2315-2320.
30. Temperini, C.; Innocenti, A.; Mastrolorenzo, A.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Interaction of the antiepileptic drug sulthiame with twelve mammalian isoforms: Kinetic and X-ray crystallographic studies. Bioorg. Med. Chem. Lett. 2007, 17, 4866-4872.
31. (a) Supuran, C. T.; Scozzafava, A.; Casini, A. Carbonic anhydrase inhibitors. Med. Res. Rev. 2003, 23, 146-189.
32. (b) Supuran, C. T.; Scozzafava, A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg. Med. Chem. 2007, 15, 4336-4350.
33. (c) Winum, J. Y.; Rami, M.; Scozzafava, A.; Montero, J. L.; Supuran, C. Carbonic anhydrase IX: A new druggable target for the design of antitumor agents. Med. Res. Rev. 2008, 28, 445-463.
34. (d) Thiry, A.; Dogne, J. M.; Masereel, B.; Supuran, C. T. Targeting tumor-associated carbonic anhydrase IX in cancer therapy. Trends Pharmacol. Sci. 2006, 27, 566-573.
35. (e) Alterio, V.; Vitale, R. M.; Monti, S. M.; Pedone, C.; Scozzafava, A.; Cecchi, A.; De Simone, G.; Supuran, C. T. Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX. J. Am. Chem. Soc. 2006, 128, 8329-8335.
36. (f) Thiry, A.; Supuran, C. T.; Masereel, B.; Dogne, J. M. Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs. J. Med. Chem. 2008, 51, 3051- 3056.
37. (g) Innocenti, A.; Firnges, M. A.; Antel, J.; Wurl, M.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human carbonic anhydrase IV with sulfonamides. Bioorg. Med. Chem. Lett. 2005, 15, 1149-1154.
38. (a) D'Ambrosio, K.; Vitale, R. M.; Dogné, J. M.; Masereel, B.; Innocenti, A.; Scozzafava, A.; De Simone, G.; Supuran, C. T. Carbonic anhydrase inhibitors: Bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII. J. Med. Chem. 2008, 51, 3230-3237.
39. (b) Menchise, V.; De Simone,G.; Alterio, V.; Di Fiore, A.; Pedone, C.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: Stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II. J. Med. Chem. 2005, 48, 5721-5727.
40. (c) De Simone, G.; Vitale, R. M.; Di Fiore, A.; Pedone, C.; Scozzafava, A.; Montero, J. L.; Winum, J. Y.; Supuran, C. T. Carbonic anhydrase inhibitors: Hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX. J. Med. Chem. 2006, 49, 5544-5551.
41. (d) Casini, A.; Antel, J.; Abbate, F.; Scozzafava, A.; David, S.; Waldeck, H.; Schafer, S.; Supuran, C. T. Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II, and IV. Bioorg. Med. Chem. Lett. 2003, 13, 841-845.
42. (e) Winum, J. Y.; Temperini, C.; El Cheikh, K.; Innocenti, A.; Vullo, D.; Ciattini, S.; Montero, J. L.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: Clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue. J. Med. Cim. 2006, 49, 7024-7031.
43. Notredame, C.; Higgins, D. G.; Heringam, J. T-Coffee: A novel method for fast and accurate multiple sequence alignment. J. Mol. Biol. 2000, 302, 205-217.
44. (a) Alterio, V.; De Simone, G.; Monti, S. M.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: Inhibition of human, bacterial and archaeal isozymes with benzene-1,3-disulfonamides-solution and crystallographic studies. Bioorg. Med. Chem. Lett. 2007, 17, 42014207.
45. (b) Temperini, C.; Scozzafava, A.; Vullo, D.; Supuran, C. T. Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with L- and D-histidine and crystallographic analysis of their adducts with isoform II: Engineering proton transfer processes within the active site of an enzyme. Chemistry 2006, 12, 7057-7066.
46. (c) Temperini, C.; Scozzafava, A.; Puccetti, L.; Supuran, C. T. Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators. Bioorg. Med Chem . Lett. 2005, 15, 5136-5141.
47. (d) Di Fiore, A.; Pedone, C.; D'Ambrosio, K.; Scozzafava, A.; De Simone, G.; Supuran, C. T. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related, cyclooxygenase II "selective" inhibitor celecoxib. Bioorg. Med. Chem. Lett. 2006, 16, 437-442.
48. (e) Di Fiore, A.; De Simone, G.; Menchise, V.; Pedone, C.; Casini, A.; Scozzafava, A.; Supuran, C. T. Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II. Bioorg. Med. Chem. Lett. 2005, 15, 1937-1942.